For many years, factors such as tumor size, axillary lymph node status, tumor histology, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), patient age, and prognosis were used to assess the prognosis and choose the best course of action for breast cancer patients [4]. Here, ERBB2 is linked to breast carcinoma.